In the BioHarmony Drug Report Database
Lodoxamide tromethamine
Alomide (lodoxamide tromethamine) is a small molecule pharmaceutical. Lodoxamide tromethamine was first approved as Alomide on 1993-09-23. It is used to treat keratoconjunctivitis in the USA.
Trade Name
|
Alomide |
|---|---|
Common Name
|
lodoxamide tromethamine |
ChEMBL ID
|
CHEMBL3989725 |
Indication
|
keratoconjunctivitis |
Drug Class
|
Image (chem structure or protein)